Post by The Lancet Gastroenterology & Hepatology

🆕 The August 2026 issue of The Lancet Gastroenterology & Hepatology is out today at https://lnkd.in/eKVUYNBP! This month's cover, by Sara Gironi Carnevale, links to an article in the issue on the association between HLA-DRB1*01:03 and patient phenotypes in inflammatory bowel disease. 🗣️ Our Editorial this month reports on new breakthroughs in treatment for pancreatic cancer. 🔬 Research on: ▶️ HLA-DRB1*01:03 in patients with inflammatory bowel disease: a genotype–phenotype association study ▶️ Dupilumab versus placebo in adults and adolescents with eosinophilic gastritis (DEGAS) ▶️ Liver stiffness dynamics in European populations (LiverScreen) ▶️ Addition of ipilimumab to atezolizumab plus bevacizumab in advanced hepatocellular carcinoma (PRODIGE 81-FFCD 2101-TRIPLET HCC) 📖 Review and opinion on: ▶️ Breaking the therapeutic ceiling in inflammatory bowel disease: myth or reality? ▶️ Balancing benefit and burden: rethinking post-polypectomy colonoscopy surveillance strategies ✍ Plenty of expert opinion and thought in our Comment & In Focus sections, including pieces on: ▶️ Metabolic syndrome myopathy ▶️ Medical mysogyny in DGBI ▶️ Impact of ransomware attacks on liver transplantation services #Gastroenterology #Hepatology #Oncology #Medicine #Healthcare Ying Shang Melinda Wang Jennifer C. Lai, MD/MBA Tiffany Taft, PsyD Tina Aswani-Omprakash, MPH Johannah Ruddy DHSc, MEd Abdul Rahman Hakeem MBBS, FRCS, PhD, FEBS, SERF (USA), FACS Qian Zhang Holm Uhlig Laura Fachal James Lee Furuta, Glenn Lisa Martin Jesse Pustjens Aleksander Krag isabel Graupera Garcia-Milà Willem Pieter Brouwer Maja Thiele Julien Edeline Virginia Solitano Vipul Jairath Fernando Magro Alessandro Armuzzi Joep IJspeert Michael Bretthauer Rodrigo Jover Martínez Evelien Dekker